期刊中文名:腫瘤醫學病例報告ISSN:2090-6706E-ISSN:2090-6714
該雜志國際簡稱:CASE REP ONCOL MED,是由出版商Hindawi Limited出版的一本致力于發布--研究新成果的的專業學術期刊。主要發表刊登有創見的學術論文文章、行業最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發展起指導作用的綜述與專論,促進學術發展,為廣大讀者服務。該刊是一本國際優秀雜志,在國際上有很高的學術影響力。
《Case Reports In Oncological Medicine》是一本以English為主的開放獲取國際優秀期刊,中文名稱腫瘤醫學病例報告,本刊主要出版、報道領域的研究動態以及在該領域取得的各方面的經驗和科研成果,介紹該領域有關本專業的最新進展,探討行業發展的思路和方法,以促進學術信息交流,提高行業發展。該刊已被國際權威數據庫SCIE收錄,為該領域相關學科的發展起到了良好的推動作用,也得到了本專業人員的廣泛認可。該刊最新影響因子為0.6,
Case Reports in Oncology Medicine is a peer-reviewed open access journal focused on the field of oncology. This magazine publishes case reports related to various cancers, aiming to provide a platform for clinical doctors, researchers, and healthcare professionals to share unique cases, rare disease manifestations, treatment challenges, and innovative therapies. These case reports help to enhance understanding of cancer biology, diagnosis, treatment, and management, while also guiding future clinical practice and research directions.
The journal emphasizes the educational significance and scientific contribution of cases, encourages submission of detailed case descriptions, comprehensive literature reviews, and in-depth discussions. In this way, the magazine not only promotes the dissemination of individual case knowledge, but also helps to build a broader oncology community, thereby improving the quality of patient care worldwide. The types of contributions accepted by the magazine include single case reports and case series, and research topics cover a wide range of fields such as breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology, and urogenital cancer. These studies are of great significance for promoting clinical progress and personalized medicine in oncology.
按JIF指標學科分區 |
學科:ONCOLOGY
收錄子集:ESCI
分區:Q4
排名:299 / 322
百分位:
7.3% |
按JCI指標學科分區 |
學科:ONCOLOGY
收錄子集:ESCI
分區:Q4
排名:298 / 322
百分位:
7.61% |
JCR分區:JCR分區來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數據的統計信息的期刊評價資源。每年發布的JCR分區,設置了254個具體學科。JCR分區根據每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區,分別為Q1、Q2、Q3和Q4,各占25%。JCR分區中期刊的數量是均勻分為四個部分的。
該雜志是一本國際優秀雜志,在國際上有較高的學術影響力,行業關注度很高,已被國際權威數據庫SCIE收錄,該雜志在綜合專業領域專業度認可很高,對稿件內容的創新性和學術性要求很高,作為一本國際優秀雜志,一般投稿過審時間都較長,投稿過審時間平均 16 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。
若用戶需要出版服務,請聯系出版商。